Published in Infect Immun on September 01, 1983
Synergistic effect of adenovirus type 1 and nontypeable Haemophilus influenzae in a chinchilla model of experimental otitis media. Infect Immun (1994) 1.94
Immunopathogenesis of polymicrobial otitis media. J Leukoc Biol (2009) 1.13
Influenza virus induces bacterial and nonbacterial otitis media. J Infect Dis (2011) 1.08
Adenovirus serotype 1 does not act synergistically with Moraxella (Branhamella) catarrhalis to induce otitis media in the chinchilla. Infect Immun (1995) 1.05
Chinchilla and murine models of upper respiratory tract infections with respiratory syncytial virus. J Virol (2005) 1.03
Sialidase-based anti-influenza virus therapy protects against secondary pneumococcal infection. J Infect Dis (2010) 0.85
Influenza A virus alters pneumococcal nasal colonization and middle ear infection independently of phase variation. Infect Immun (2014) 0.85
Mapping the anatomy of respiratory syncytial virus infection of the upper airways in chinchillas (Chinchilla lanigera). Comp Med (2010) 0.79
Effectiveness of pandemic influenza A/H1N1 vaccine for prevention of otitis media in children. Eur J Pediatr (2012) 0.75
Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines. Infect Immun (1982) 2.61
A longitudinal study of respiratory viruses and bacteria in the etiology of acute otitis media with effusion. N Engl J Med (1982) 2.52
Interaction of influenza virus with leukocytes and its effect on phagocytosis. J Infect Dis (1969) 2.50
Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-1A2 and cold-adapted recombinant viruses in seronegative adult volunteers. Infect Immun (1980) 2.42
Canine kidney cell line for isolation of respiratory viruses. J Clin Microbiol (1979) 2.25
Combined infections in mice with influenza virus and Diplococcus pneumoniae. Am J Hyg (1957) 1.98
Differing virulence of H1N1 and H3N2 influenza strains. Am J Epidemiol (1980) 1.97
Bacterial adherence to pharyngeal cells during viral infection. J Infect Dis (1980) 1.68
The influence of influenza virus infection on exogenous staphylococcal and endogenous murine bacterial infection of the bronchopulmonary tissues of mice. J Exp Med (1961) 1.57
Otitis media in infants and children. Pediatrics (1980) 1.44
Experimental otitis media after nasal inoculation of Streptococcus pneumoniae and influenza A virus in chinchillas. Infect Immun (1980) 1.43
Polymorphonuclear leukocyte dysfunction during influenza virus infection in chinchillas. J Infect Dis (1981) 1.38
Experimental otitis media due to Streptococcus pneumoniae: immunopathogenic response in the chinchilla. J Infect Dis (1976) 1.31
Evaluation of A/Alaska/6/77 (H3N2) cold-adapted recombinant viruses derived from A/Ann Arbor/6/60 cold-adapted donor virus in adult seronegative volunteers. Infect Immun (1981) 1.27
Pilot studies on recombinant cold-adapted live type A and B influenza virus vaccines. J Infect Dis (1977) 1.25
Influenza A virus-induced polymorphonuclear leukocyte dysfunction in the pathogenesis of experimental pneumococcal otitis media. Infect Immun (1982) 1.23
Modification of otitis media following vaccination with the capsular polysaccharide of Streptococcus pneumoniae in chinchillas. J Infect Dis (1978) 1.21
Cilia and mucus transport as determinants of the response of lung to air pollutants. Arch Environ Health (1967) 1.20
Depression of human neutrophil motility by influenza virus in vitro. Scand J Immunol (1977) 1.06
The pathogenesis of pneumococcal otitis media in chinchillas and the efficacy of vaccination in prophylaxis. Rev Infect Dis (1981) 0.99
Tympanometric configurations and middle ear findings in experimental otitis media. Ann Otol Rhinol Laryngol (1982) 0.98
Influenza viruses and staphylococci in vitro: some interactions with polymorphonuclear leucocytes and epithelial cells. Br J Exp Pathol (1977) 0.94
Influenza infection in the infant mouse. Pediatr Res (1983) 0.92
Coexisting viral (respiratory syncytial) and bacterial (pneumococcus) otitis media in children. Acta Otolaryngol (1968) 0.89
Permeability of the middle ear to staphylococcal pyrogenic exotoxin in otitis media. Int J Pediatr Otorhinolaryngol (1980) 0.86
The effect of influenza virus on human polymorphonuclear leukocytes. Antonie Van Leeuwenhoek (1980) 0.85
The round window membrane following application of staphylococcal exotoxin: an electron microscopic study. Laryngoscope (1981) 0.84
Prediction of serous versus purulent otitis media by otoscopy and tympanometry in an animal model. Laryngoscope (1983) 0.82
Infant rat model of attenuation for recombinant influenza viruses prepared from cold-adapted attenuated A/Ann Arbor/6/60. Infect Immun (1982) 0.80
Eustachian tube function and allergy in otitis media. Pediatrics (1978) 0.80
Sudden death caused by interaction between a macroglobulin and a divalent drug. Lancet (1976) 0.79
Effect of tympanostomy tubes on the pathogenesis of acute otitis media. Am J Otolaryngol (1982) 0.77
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06
The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med (2000) 8.46
Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J (1999) 5.88
Rates of hospitalization for respiratory syncytial virus infection among children in medicaid. J Pediatr (2000) 4.08
Clinical efficacy of antimicrobial drugs for acute otitis media: metaanalysis of 5400 children from thirty-three randomized trials. J Pediatr (1994) 3.88
Primary respiratory syncytial virus infection in mice. J Med Virol (1988) 3.77
Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J Clin Invest (1991) 3.71
Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness. J Immunol (1971) 3.33
Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev Infect Dis (1992) 3.07
Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines. Infect Immun (1982) 2.61
A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis (1994) 2.52
Canine kidney cell line for isolation of respiratory viruses. J Clin Microbiol (1979) 2.25
Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children < 5 years old. J Infect Dis (1997) 2.12
Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection. J Clin Microbiol (1986) 2.09
Comparison of competitive and indirect enzyme-linked immunosorbent assays for detection of bluetongue virus antibodies in serum and whole blood. J Clin Microbiol (1987) 2.07
Differing virulence of H1N1 and H3N2 influenza strains. Am J Epidemiol (1980) 1.97
Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine. J Infect Dis (1986) 1.97
An analytical model applied to a multicenter pneumococcal enzyme-linked immunosorbent assay study. J Clin Microbiol (2000) 1.97
Temperature-sensitive mutants of respiratory syncytial virus. J Virol (1969) 1.94
Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV. Infect Immun (1977) 1.92
Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience. Pediatr Infect Dis J (2001) 1.90
Comparison of long-term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine. J Med Virol (1985) 1.88
Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children. J Infect Dis (1997) 1.86
The burden of influenza illness in children with asthma and other chronic medical conditions. J Pediatr (2000) 1.85
Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity. J Infect Dis (1994) 1.78
Adenovirus infections in young children. Pediatrics (1985) 1.76
Changing presentation of herpes simplex virus infection in neonates. J Infect Dis (1988) 1.76
Validity of parental report of a child's medical history in otitis media research. Am J Epidemiol (1994) 1.75
A live attenuated bovine parainfluenza virus type 3 vaccine is safe, infectious, immunogenic, and phenotypically stable in infants and children. J Infect Dis (1995) 1.68
Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network. J Infect Dis (1993) 1.67
Cytomegalovirus pneumonia in two infants recently adopted from China. Clin Infect Dis (1999) 1.65
The natural history of human immunodeficiency virus 1 infection in Haitian infants. Pediatr Infect Dis J (1999) 1.64
Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group. J Infect Dis (1998) 1.64
Administration of a highly attenuated, live respiratory syncytial virus vaccine to adults and children. Infect Immun (1982) 1.61
Cold-adapted recombinant influenza A virus vaccines in seronegative young children. J Infect Dis (1982) 1.61
Development of subtype-specific and heterosubtypic antibodies to the influenza A virus hemagglutinin after primary infection in children. J Clin Microbiol (1985) 1.59
The bacteriology and cytology of chronic otitis media with effusion. Pediatr Infect Dis (1983) 1.55
Splenic reticuloendothelial function after splenectomy, spleen repair, and spleen autotransplantation. N Engl J Med (1987) 1.54
Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virus. J Infect Dis (1988) 1.52
Twenty years of outpatient respiratory syncytial virus infection: a framework for vaccine efficacy trials. Pediatrics (1997) 1.51
Temperature-sensitive mutants of respiratory syncytial virus: in-vivo studies in hamsters. J Infect Dis (1970) 1.51
Comparison of influenza B/Hong Kong virus infections among infants, children, and young adults. J Infect Dis (1980) 1.47
Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group. J Infect Dis (1998) 1.47
Safety and antigenicity of influenza A/Hong Kong/68-ts-1 (E) (H3N2). J Pediatr (1975) 1.45
Overwhelming postplenectomy infection. Surg Clin North Am (1979) 1.45
Experimental otitis media after nasal inoculation of Streptococcus pneumoniae and influenza A virus in chinchillas. Infect Immun (1980) 1.43
Candidate AIDS vaccines. N Engl J Med (1995) 1.41
Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells. J Infect Dis (1983) 1.41
A penicillin-resistant pneumococcus. J Pediatr (1978) 1.40
Reinfection of mice with respiratory syncytial virus. J Med Virol (1991) 1.39
Polymorphonuclear leukocyte dysfunction during influenza virus infection in chinchillas. J Infect Dis (1981) 1.38
Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children. Vaccine (1999) 1.37
Genetic studies of respiratory syncytial virus temperature-sensitive mutants. Arch Gesamte Virusforsch (1973) 1.36
A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in healthy infants and children. J Infect Dis (1995) 1.36
Influenza A infections in young children. Primary natural infection and protective efficacy of live-vaccine-induced or naturally acquired immunity. N Engl J Med (1977) 1.32
Serum antibody and opsonic responses to vaccination with pneumococcal capsular polysaccharide in normal and splenectomized children. J Infect Dis (1980) 1.32
Experimental otitis media due to Streptococcus pneumoniae: immunopathogenic response in the chinchilla. J Infect Dis (1976) 1.31
Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants. J Pediatr (1976) 1.31
The microbiology of serous and mucoid otitis media. Pediatrics (1979) 1.30
Disseminated infection with Fusarium in recipients of bone marrow transplants. Rev Infect Dis (1992) 1.30
Depression of monocyte and polymorphonuclear leukocyte oxidative metabolism and bactericidal capacity by influenza A virus. Infect Immun (1982) 1.29
Growth of influenza A virus in primary, differentiated epithelial cells derived from adenoids. J Virol (1996) 1.29
Trials of influenza A/New Jersey/76 virus vaccine in normal children: an overview of age-related antigenicity and reactogenicity. J Infect Dis (1977) 1.26
Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network. J Infect Dis (1992) 1.25
Epidemiology of otitis media onset by six months of age. Pediatrics (1999) 1.24
The overwhelming postsplenectomy sepsis problem. World J Surg (1980) 1.23
Influenza A virus-induced polymorphonuclear leukocyte dysfunction in the pathogenesis of experimental pneumococcal otitis media. Infect Immun (1982) 1.23
Serum immunoglobulin G antibody subclass responses to respiratory syncytial virus F and G glycoproteins after primary infection. J Clin Microbiol (1986) 1.22
Modification of otitis media following vaccination with the capsular polysaccharide of Streptococcus pneumoniae in chinchillas. J Infect Dis (1978) 1.21
Respiratory syncytial virus infection in anti-mu-treated mice. J Virol (1991) 1.20
The contribution of pneumococcal cell wall to the pathogenesis of experimental otitis media. J Infect Dis (1988) 1.20
Humoral and cellular immune responses of seronegative children vaccinated with a cold-adapted influenza A/HK/123/77 (H1N1) recombinant virus. Infect Immun (1980) 1.19
Recombinant baculovirus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adults. J Infect Dis (1996) 1.19
Otitis media among children in day care: epidemiology and pathogenesis. Rev Infect Dis (1986) 1.17
Electron microscopic studies of respiratory syncytial temperature-sensitive mutants. Arch Gesamte Virusforsch (1973) 1.16
Clinical studies of pneumococcal vaccines in infants. I. Reactogenicity and immunogenicity of two polyvalent polysaccharide vaccines. Rev Infect Dis (1981) 1.15
Secretory immunological response after intranasal inactivated influenza A virus vaccinations: evidence for immunoglobulin A memory. Infect Immun (1983) 1.14
Age-related response to two Haemophilus influenzae type b vaccines. J Pediatr (1982) 1.14
A multi-laboratory evaluation of an enzyme-linked immunoassay quantitating human antibodies to Streptococcus pneumoniae polysaccharides. Immunol Invest (2001) 1.13
Serum antibody response to pneumococcal vaccine in children with nephrotic syndrome. Pediatrics (1982) 1.13
Immune correlates of protection against influenza in the human challenge model. Dev Biol (Basel) (2003) 1.13
Role of respiratory tract proteases in infectivity of influenza A virus. J Infect Dis (1987) 1.13
Evaluation of the safety of amantadine-HC1 and the role of respiratory viral infections in children with cystic fibrosis. J Infect Dis (1976) 1.12
Evaluation of a temperature-sensitive mutant of respiratory syncytial virus in adults. J Infect Dis (1971) 1.12
Otitis media: the spectrum of middle ear inflammation. Annu Rev Med (1978) 1.12
Animal models for studying pneumococcal otitis media and pneumococcal vaccine efficacy. Ann Otol Rhinol Laryngol Suppl (1981) 1.11
A colorimetric microtiter plate PCR system detects respiratory syncytial virus in nasal aspirates and discriminates subtypes A and B. Diagn Microbiol Infect Dis (1999) 1.11
A comparison of five serological tests for bovine brucellosis. Can J Vet Res (1986) 1.10
Measurement of immunoglobulin G and M antibodies to type 3 pneumococcal capsular polysaccharide by enzyme-linked immunosorbent assay. J Clin Microbiol (1982) 1.07
Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenza vaccines administered intranasally to healthy adults. Vaccine (2000) 1.07
High frequency hearing loss associated with otitis media. Ear Hear (1996) 1.06
Experimental animal models for studying antimicrobial pharmacokinetics in otitis media. Pharm Res (1989) 1.06
Phagocytosis of Candida albicans by human leukocytes: opsonic requirements. J Infect Dis (1978) 1.05
Aprotinin and similar protease inhibitors as drugs against influenza. Antiviral Res (2011) 1.05
Determining risk for chronic otitis media with effusion. Pediatr Infect Dis J (1988) 1.04
Lack of comparability between commonly used serological assays of immune response to Haemophilus influenzae vaccine. J Infect Dis (1987) 1.04
Safety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3 or 4 in adults, children and infants. Vaccine (1999) 1.04
Application of a timing protocol to the reduction of inter-plate variability in the indirect enzyme immunoassay for detection of anti-Brucella antibody. J Immunoassay (1985) 1.04